Funding for this research was provided by:
National Heart, Lung, and Blood Institute (1 R43 HL149598-01)
National Institute for Innovation in Manufacturing Biopharmaceuticals (70NANB17H002)
Received: 15 April 2021
Accepted: 19 October 2021
First Online: 1 November 2021
: The authors declare the following competing interests: all authors are employees and/or equity holders of CellFE, Inc., a company developing microfluidic-based cell engineering products.